The Functional Nanogel: An Exalted Carrier System by Kesharwani, Disha et al.
Kesharwani et al                                                                                                Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):570-582 
ISSN: 2250-1177                                                                                  [570]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.04.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                                   Review Article 
The Functional Nanogel: An Exalted Carrier System 
Disha Kesharwani 1, Sandhya Mishra1, Swarnali Das Paul 2, Rishi Paliwal 3, Trilochan Satapathy 1 
1 Columbia Institute of Pharmacy, Raipur, Chhattisgarh, India  
2 Faculty of Pharmaceutical Sciences, SSTC, SSGI, Bhilai, C.G, India 
3 Faculty of Pharmacy, IGNTU, Amarkantak, Madhya Pradesh, India 
 
ABSTRACT 
Nanotechnology is widely growing field nowadays. Under these vast variety of carriers are available through which the drugs c an be delivered to 
the affected organ. Nanogels are one of the most effective carrier systems for targeting the drugs directly to the diseased tissues with their highly 
adaptive properties. Nanogel can be defined as nanoparticles incorporated in hydrogel. These systems are very efficient in embodying drugs of 
diverse nature and also in enhancing their delivery and retention to the targeting organ. Due to their targeting properties they reduce the dose of 
drug required in free form and also reduces the side effects produced by accumulation of drugs to any other organ. This review highlights 
various types of nanogels, their advantages, most commonly used preparation techniques, biomedical applications, drug targeting through 
nanogels, drug loading and release through the nanogels. The review has also incorporated the recent patents related to the topic. However, 
there is an urgent need for relevant clinical data from nanogels so as to allow translation of the nanogel concept into a viable therapeutic 
application for the treatment of cancer.  
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INTRODUCTION 
In the current era of drastic improvements in diagnosis and 
therapy of diseases, Nanotechnology is a newly introduced 
field of drug delivery. Nanotechnology is also completely 
involved in imaging and diagnostic tests, hormone therapy, 
bone replacement, and in prescriptions of almost all kinds of 
illness. Under nanotechnology polymer based materials, 
nanogels are getting great consideration due to their magical 
potentials.1,2 
Nanogels are basically nanoparticles incorporated in 
hydrogel system. Fig. 1 shows the basic composition of 
nanogels. These are the advanced delivery systems which 
possess the properties of both nanoparticles and hydrogels.  
These formulations are also known as nanohydrogels, 
nanogels or hydrogel nanoparticles. Nanoparticle have many 
advantages over the traditional formulations such as a 
controlled drug release, protection from degradation, 
delayed elimination, stimuli responsive behavior etc. 3,4 
The hydrogel delivery systems consist of three dimensional 
cross linked structures of polymers attached with non-
covalent bonds. This structure is suitable for loading and 
release of drugs specially of natural origin. They have a large 
capacity of imbibing water inside their structure and swell to 
a greater extent. The imbibed water maintains the fluid like 
consistency. Their water absorbing capacity is an indication 
of their hydrophilic functional groups such as –OH, -COOH, - 
CONH2, - CONH- etc. The nanoparticle size ranges from 20 to 
200 nm. The nanogel delivery systems are more 
advantageous than the original hydrogels because the 
former can be injected directly to the target site and can 
release the drugs for both local and systemic action. Ligands 
can be added by chemical modification for facilitating the 
targeting action. These nanogels systems also incorporate 
noticeable thermodynamic stability, enhanced solubilization 
capacity, low viscosity and higher capacity to withstand the 
sterilization procedures. These properties improve the 
release characteristics.5 
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Figure 1; Basic Composition of Nanogel 
 
Nanogel term was first time reported by Vinogradov et al., 
1999 in the scientific paper. They prepared it as a 
hydrophilic polymer network by chemically crosslinking 
poly(ethylene glycol). Whereas, Akiyoshi described the first 
physically cross-linked nanogels using self-assembly of 
cholesterol-bearing polysaccharides in water.6 
Fig. 2 compiles all the benefits of nanogel carrier system. 
Nanogels are highly biocompatible as they are made up of 
either natural or synthetic polymers. This biocompatible and 
biodegradable nature avoids its accumulation in the organs. 
The common natural polymers utilized for this purpose are 
collagen, fibrin, albumin, polysaccharide based polymers like 
chitosan, ethyl cellulose, hyaluronic acid, chondritin 
sulphate, heparin, dextrane, pullulan etc. These polymers 
provide swelling properties to the nanogels which helps in 
controlled drug release from the system. Poly(lactic acid), 
poly(lactic)–poly(glycolic) copolymers, polyacrylates and 
polymethacrylates, poly(e-caprolactone), are some typically 
synthetic polymers for nanogel preparation. Nanogels can 
incorporate any kind of drug inside them. Therefore these 
are advanced media for the delivery of poorly soluble drugs. 
7 
These polymers based drug delivery systems are of 
particular advantage in targeting the drug to the required 
site with lesser side effects in case of fatal diseases like 
cancer. 
Nanogels can be administered by variety of routes, including 
oral, pulmonary, nasal, parenteral, intra- ocular and topical. 
These systems are formulated in a specific manner with a 
diameter of 20-200 nm, which is sufficiently small to 
permeate blood brain barrier and at the same time can avoid 
clearance. They have the ability to respond to environmental 
changes such as pH and temperature.  Nanogels have high 
loading capacity for guest molecules ranging from inorganic 
nanoparticles to drugs, bio-macromolecules like proteins 
and DNA, with appropriate adaptation of their structure, but 
without affecting the gel-like performances. 
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Figure 2: Benefits of Nanogel 
Swelling of nanogels in water is governed by several factors like cross- linker concentration and environmental parameters like 
pH, temperature, ionic concentration etc. 8 
CLASSIFICATION 
 
Figure 3: Classification of nanogels on different basis 
Nanogels can be classified into various classes based on their 
behavior towards environmental stimuli, the type of linkage 
present etc.  Fig. 3 describes the classification. The swelling 
of stimuli responsive nanogels is affected by various 
environmental factors such as light, pH, ionic strength, 
temperature and magnetic field, but, the same for non- 
responsive nanogels is unaffected by these factors. It just 
absorbs water and swells. In another classification physically 
cross linked gels involve weaker bonds like hydrophobic 
bonds, vanderwaal forces, and hydrogen bonds. In this case 
the formation of microgels and nanogels takes only a few 
minutes. Physical gels can also be formed by the aggregation 
and/or self-assembly of polymeric chains. The chemically 
cross linked nanogels involve strong and permanent 
covalent bonds in their networks. The types of covalent bond 
depend on type of functional group present in the structure. 
9
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Preparation of Nanogels:  
Fig. 4 and fig. 5 decribe the broad classification and general preparation techniques of nanogels. 
 
Figure 4: Broad Classification of Preparation of Nanogels 
 
Most Commonly Used Methods (10): 
1. Ionic gelation method 
2. Emulsion polymerization 
3. Solvent emulsification/ evaporation method / Emulsion 
solvent evaporation technique 
4. Solvent Displacement method/ nano-precipitation 
method 
5. Emulsion solvent diffusion method 
6. Coacervation/Precipitation/ Precipitation 
polymerization 
7. Emulsion cross- linking 
8. Emulsion droplet coalescence method 
9. Desolvation method 
10. Micro-emulsion template method 
1. Ionic gelation method-Using ionic gelation method, 
there are two techniques by which hydrogel beads (also 
called as gelispheres) can be prepared. The basis of 
classification of the techniques is the source of cross 
linking ion  
(a) External Ionic gelation-In this method, the position of 
cross linker ion is outside the polymer solution. 
(b) Internal Ionic gelation/Emulsification-In the second 
method, the polymer solution embodies the cross-linker 
ion in inactive form. 10 
Amongst these two methods the first method is most 
extensively used because of formation of thin films with 
smoother surface, greater matrix strength, stiffness, 
permeability than internally cross-linked films and also have 
greater drug encapsulation efficiency and slower drug 
release rate. 
In the external ionic gelation method, a drug polymer 
solution is prepared and then it is added dropwise into the 
aqueous counter ion solution which leads to the diffusion of 
drug loaded polymeric drop and cations of counter ion 
solution,  forming a three dimensional lattice  of ionically  
crosslinked moiety called gelispheres. 11 
2. Emulsion polymerization method 
On the basis of the type of the continuous phase, emulsion 
polymerization can be classified into-(a) Aqueous 
continuous phase containing emulsion polymerization  
(b) Organic continuous phase containing emulsion 
polymerization. 
The major emulsion polymerization techniques involve 
conventional emulsion polymerization, surfactant-free 
emulsion polymerization, as well as mini- (or 
nanoemulsions) and microemulsions polymerizations. This 
method can be divided into three phase nucleation, particle 
growth phase and polymerization. The process involves 
hydrophobic monomer, dispersion media, initiator and 
surfactant as the main component for emulsification. When 
monomer is emulsified in water and the concentration of 
surfactant exceeds the critical micellar concentration (CMC), 
formation of micelles occur, which causes reduction of 
surface tension at the surface and entry of monomers inside 
the micelles. Then the initiator is added and the micelle act 
as as reaction site of monomer and free radical. The step of 
polymerization starts and the micelle grows by continuously 
adding monomers. 12 
3. Solvent emulsification/ evaporation method 
/Emulsion solvent evaporation technique 
In this method, a drug and polymeric solution is prepared in 
an organic solvent and then it is added to an aqueous 
continuous phase containing stabilizer with continuous 
magnetic stirring at room temperature or under reduced 
pressure which leads to the formation of emulsions. After the 
formation of nanoemulsion, it is converted to nanoparticle 
suspension due to the evaporation of solvent from water-air 
interface until saturation is achieved leading to the diffusion 
of solvent from an inner droplet of emulsion to the external 
continuous phase.It results in the formation of solidified 
nanosized particles which is collected by ultra-centrifugation 
and finally lyophilized. 12,13 
4. Nano- Precipitation  
This method is basically based on the interfacial deposition 
of polymers following the displacement of a semi-polar 
solvent miscible with water from a lipophilic solution. It is 
mainly preferred for hydrophobic drugs. It requires two 
miscible organic and aqueous solvents. For the preparation 
of nanoparticle by this method the drug is mixed with 
polymer in a specific ratio.  The nanoparticle formation 
requires three phases: nucleation, growth and aggregation. 
Supersaturation is the most important step for 
determination of nucleation rate. The difference between the 
surface tensions of two of the liquids plays an important role 
in the formation of nanoparticles. 13, 14 This difference 
between surface tensions of the aqueous and the oil phase 
causes interfacial turbulence and thermal inequalities in the 
system. This leads to the continuous formation of vortices of 
solvent at the interface of both liquids. The organic solvent 
diffuses from regions of low surface tension which causes 
gradual precipitation of the polymer on the oil surface and 
formsb nanocapsules.  The prepared nanoparticles are then 
dispersed in gel using a magnetic stirrer. Penetration 
enhancers, humectants and pH modifiers are added. 14 
5. Emulsion solvent diffusion method: 
In this method, weighed amount drug, polymer and stabilizer 
are dissolved in glycerol with continuous stirring. For 
aqueous phase a gelling agent is dissolved in water with 
continuous stirring and heat. The drug containing   phase is 
ultrasonicated. After that the drug phase is added dropwise 
to the aqueous phase with homogenization to form emulsion. 
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Further the emulsion is reduced to nanodroplets by 
homogeniger at 5000- 8000 rpm for 1 hour. The prepared 
emulsion is O/W emulsion. Penetration enhancer is used for 
increasing the efficiency of the preparation and pH is 
adjusted. 15 
6. Coacervation/Precipitation/ Precipitation 
Polymerization 
This method utilizes the physicochemical properties of 
polymers involved. As with chitosan, its insolubility in 
alkaline solution is utilized. This polymer is insoluble at 
alkaline pH and when comes in contact, it precipitates. A 
compressed nozzle spray is used to control the particle size 
of polymer containg drug. The particles are then separated 
using centrifugation and washed with hot and cold water. 16  
7. Emulsion Cross-Linking  
This method is based on cross-linking of  reactive functional 
groups of polymer and cross- linking agent. In this method 
an emulsion (w/o) is prepared by dispersing the aqueous 
solution of polymer in the oil phase. A suitable surfactant 
and cross-linking agents are added to stabilize the solution 
and harden the droplets respectively. The obtained 
nanospheres are then washed with organic solvents and 
dried. 16 
8. Emulsion-droplet coalescence method  
This method involves the concepts of both the emulsion 
cross-linking and precipitation method with slight 
modification. In contrast to the cross-linking method, it 
induces the precipitation by allowing coalescence of polymer 
droplets. In the first step aqueous polymer solution is 
emulsified with a suitable oil. Then another emulsion of the 
same polymer containing drug is prepared with the alkaline 
pH. Both the emulsions are then mixed with high speed 
homogenization. The droplets collide and coalescence, which 
results in precipitation of small particles. The particles are 
separated by centrifugation, washed and dried. 16,17 
 
9. Desolvation method 
In this method generally high molecular weight polymers are 
used such as gelatin and it is dissolved in double distilled 
water under heating and continuous stirring. The prepared 
aquous phase is allowed to stand at room temperature for 10 
minutes and the a calculated amount of desolvating agent 
(i.e. ethanol) is added immediately to precipitate the high 
molecular weight polymer. The supernatant liquid is 
discarded & the high molecular weight polymer is again 
dissolved in double distilled water containing drug. The The 
prepared solution is then stirred under 500-1000 rpm for 8 
hours at a constant temperature. pH is adjusted. In the 
second desolvation step, In-situ nanoparticle is formed by 
adding desolvating agent drop-wise with constant stirring. 
When turbidity is observed in the solution the solution is 
allowed to stand for 10 minutes and a crosslinking agent is 
added and further stirred at 500- 1000 rpm for 8 hours. The 
resulting solution is centrifuged, the settled nanoparticle are 
collected and washed  whereas the supernatant is discarded. 
17 
10. Tempelate Method 
Photolithography is used to formulate 3 dimensional 
hydrogel particles and nanogels for drug delivery. This 
method involves the use of replica molds for molding gels. It 
requires the development of treatment methods of molds for 
easy release of molded gels from replica. This method 
consists of five basic steps 
(a) UV cross linkable polymer is taken as a substrate on 
pre- baked photo resist coated water.  
(b) Molding of polymer into predetermined patterns by 
pressingthe quartz template on to the polymer. Then it 
is exposed to high wavelength UV light. 
(c) Thin film layer is uncovered by removing the quartz 
template. 
(d) Oxidation of this layer. 
(e) Collection of fabricatedparticles by dissolution of 
substrate.18
 
 
Figure 5: General Preparation Techniques of Nanogel 
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Table 1: Biomedical Applications of Nanogels 
S.No Author name  Description Benefits Ref 
CANCER 
1. Vinogradov, S.V., Kohli, 
E. and Zeman, A.D. 
Nanogel carrier made up of amphipilic 
polymers and cationic polyethylenamine 
was prepared to deliver and encapsulate   
cytotoxic nucleoside analogs 5′- 
triphosphates (NTP) for the treatement of 
cancer. 
Nanogel made up of Pluronic® F68 and 
P123 with improved delivery and advance 
therapeutic potential for NTP analogs in 
comparison to NG(PEG) was prepared for 
the treatment of cancer with chemotherapy. 
19 
2. Shi, B., Huang, K., Ding, 
J., Xu, W., Yang, Y., Liu, 
H., Yan, L. and Chen, X 
They formulated a pH and reduction dual-
responsive polypepetide nanogel which 
was loaded with doxorubicin,  with the help 
of sequential dispersion and dialysis 
technique. Certain tumor suppression 
activities were confirmed by 
histopathological and 
immunohistochemical analysis of NC/DOX.   
It can be concluded that the developed 
doxorubicin nanogel had excellent in vitro 
& in vivo properties, improved on-demand 
intracellular delivery of antitumor drug, 
high drug loading capacity and also respond 
according to different environmental 
stimuli in comparison to free DOX.HCl. 
20 
3. Reeves, A., 
Vinogradov, S.V., 
Morrissey, P., Chernin, 
M. and Ahmed, M.M. 
In their work,curcumin being a potent 
anticancer compound was formulated into 
nanogel using NG127 amphiphilic 
Poloxamer-cationic network for its 
encapsulation which was found helpful in 
the  treatment of breast cancer. 
They developed curcumin nanogel had 
enhanced aqueous solubility and 
bioavailability, which ultimately enhanced 
its therapeutic activity with increased 
potential to specific tumor targeting, by 
using antibodies against surface receptors 
specific to breast cancer cells in comparison 
to carcumin alone.  
21 
4 Ashwanikumar, N., 
Kumar, N.A., Nair, S.A. 
and Kumar, G.V. 
They prepared a 5-Fluorouracil         nanogel 
using Methacrylic acid and 2-ethyl hexyl 
acrylate copolymer which effectively 
treated colon cancer.  
 
With the help of cell proliferation assay of a 
human colon tumor colon cancer cell line 
(HCT-116),the study concluded that 5-FU-
loaded MAEHA nanogels were considerably 
cytotoxic in comparison with free 5-FU. 
22 
5 Yang, W.J., Zhou, P., 
Liang, L., Cao, Y., Qiao, 
J., Li, X., Teng, Z. and 
Wang, L. 
A nanogel-incorporated injectable hydrogel 
was prepared which was loaded with 
combretastatin-A4 phosphate (CA4P) and 
doxorubicin (DOX) to produce a synergistic 
effect for the treatment of cancer. 
The prepared dual drug injectable hydrogel 
with embedded nanogel was found to more 
therapeutically active and also showed 
reduced drawbacks like drug resistance, 
high dose and is universally acceptable 
drug carrier for local delivery of dual drug 
in treatment of cancer. 
23 
6. Ohya, Y., Takahashi, A. 
and Kuzuya, A 
They prepared a dextrane(Dex) nanogel 
having a disulphide bond linked 
oligolactide chain(OLA) along with 
galactose(Gal)and 
tetraethylenepentamine(EI4) to enhance 
drug delivery by controlling intracellular 
traffic. 
The developed EI4/Gal-Dex-g-SS-OLA 
(nanogel) was found to have highly 
effective drug delivery system by collapsing 
in cytosol   under reductive condition as in 
the case of cancer chemotherapy.  
24 
7.  Hoelzer, D., Leiske, 
M.N., Hartlieb, M., Bus, 
T., Pretzel, D., 
Hoeppener, S., Kempe, 
K., Thierbach, R. and 
Schubert, U.S  
The synthesis of a new nanogel drug carrier 
system loaded with the anti-cancer drug 
doxorubicin (DOX) is presented. Poly(2-
oxazoline) (POx) based nanogels from block 
copolymer micelles were cross-linked and 
covalently loaded with DOX using pH 
sensitive Schiff’ base chemistry. 
The POx based nanogel system revealed a 
therapeutic efficiency despite the low DOX 
concentrations and could be a promising 
strategy to control tumor growth with 
fewer side effects. 
25 
8. Neshastehriz, A., 
Khateri, M., Ghaznavi, 
H. and Shakeri-Zadeh, 
A. 
They developed an alginate nanogel co-
loaded with AuNPs and cisplatin (ACA) and 
studied its chemo-radiotherapeutic effects 
on U87-MG human glioblastoma cells for 
treatment of brain tumor      
The developed alginate nanogel co-loaded 
with gold nanoparticles and cisplatin was 
found to have enhanced therapeutic ratio of 
human glioblastoma radiation therapy. 
 
26 
9 Azadi, A., Hamidi, M., 
Khoshayand, M.R., 
Amini, M. and Rouini, 
M.R. 
They prepared a chitosan and sodium 
tripolyphosphate nanogels loaded with 
methotrexate (MTX) by ionic gelation 
process for the treatment of brain 
disorders. 
The developed nanogel was found to be 
highly effective for certain brain disorders. 
27 
10. Shi, B., Huang, K., Ding, 
J., Xu, W., Yang, Y., Liu, 
H., Yan, L. and Chen, X. 
They formulated a pH and reduction dual-
responsive polypepetide nanogel which 
was loaded with doxorubicin,  with the help 
of sequential dispersion and dialysis 
technique. Certain tumor suppression 
activities were confirmed by 
It can be concluded that the developed 
doxorubicin nanogel had excellent in vitro 
& in vivo properties,improved on-demand 
intracellular delivery of antitumor drug, 
high drug loading capacity and also respond 
according to different environmental 
28 
Kesharwani et al                                                                                                Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):570-582 
ISSN: 2250-1177                                                                                  [576]                                                                                 CODEN (USA): JDDTAO 
histopathological and 
immunohistochemical analysis of NC/DOX.   
stimuli in comparison to free DOX.HCl. 
SKIN DISEASE 
11 Avasatthi, V., Pawar, 
H., Dora, C.P., Bansod, 
P., Gill, M.S. and 
Suresh, S. 
They developed nanostructured lipid 
carriers of methotrexate and incorporated 
it into nanogel. 
Along with this they evaluated its efficacy in 
imiquimod-induced psoriasis model. 
The prepared nanogels shown sustained 
and optimized release  of methotrexate. 
They reduced the signs and symptoms of 
the disease significantly and proved better 
formulation than the existing one. 
29 
12 Mujahid, M., Ahmad, L. 
and Ahmad, M. 
They developed Zinc oxide nanoparticle 
incorporated in the gel which enhanced the 
surface volume ratio and shown more 
efficiency than the existing gels that are 
prepared from traditional methods for the 
treatment of superficial skin microbial 
infection.  
Preparation of Zinc oxide nanogel showed 
maximum antibacterial activity as 
nanoparticles present in it helped to kill 
biofilms present on the infected skins by 
increasing UV activity as compared to 
conventional ZnO gels. 
30 
13 Panonnummal, R., 
Jayakumar, R., 
Anjaneyan, G. and 
Sabitha, M. 
They prepared a chitin nanogel loaded with 
methotrexate for treatment of psoriasis.    
The prepared methotrexate loaded chitin 
nanogel was found to have high psoriatic 
activity with high serum and tissue level of 
methotrexate without systemic toxicity in 
comparison to methotrexate tablets.  
31 
INFLAMMATION 
14 Singka, G.S.L., Samah, 
N.A., Zulfakar, M.H., 
Yurdasiper, A. and 
Heard, C.M. 
They prepared a methothrexate loaded 
nanogel co-polymerised with N-
isopropylacrylamide (NIPAM) and 
butylacrylate (BA) and examined the effect 
of sodium carbonate on topical application 
of nanogel for treatment of inflammation.   
The prepared nanogel with sodium 
bicarbonate was found to have a more 
methotrexate release in comparison to 
other conventional preparations. 
32 
15 Talele, S., Nikam, P., 
Ghosh, B., Deore, C., 
Jaybhave, A. and 
Jadhav, A. 
They enhance the bioavailability and anti-
inflammatory effect of Diclofenac sodium 
by developing nanogel. 
The drug release was enhanced by using 
carbopol 940 as gelling agent, propylene 
glycol as permeation enhancer and Eudragit 
S-100 as comapared to plane nanogel with 
HPMC and MC. 
33 
16 Pawar, S. and Pande, V. They developed a biodegradable, surface 
decorated zaltoprofen nanogel using gelatin 
as a base and its texture characteristics 
were also evaluated. 
The developed zaltoprofen nanogel was 
found to give better patient 
compliance,sustained analgesic activity and 
more stability  as compared to marketed 
nanogel due to its acceptable texture 
characteristics and bio-adhesive properties 
and three months stability. 
 
34 
MICROBIAL INFECTION  
17 Kłodzińska, S.N., 
Molchanova, N., 
Franzyk, H., Hansen, 
P.R., Damborg, P. and 
Nielsen, H.M. 
They developed a lysine-based α-
peptide/β-peptoid hybrid biopolymer 
nanogel incorporating octenyl succinic 
anhydride-modified hyaluronic acid along 
with anti-bacterial peptidomimetic for the 
treatment of pseudomonas aeruginosa 
caused infection.  
It can be concluded that the antibacterial 
peptidomimetic nanogel prepared was 
found to have reduced cytoxicity, more cell 
selective, high efficacy of encapsulation and 
also enhanced bacteria killing kinetics in 
comparison to simple peptidomimetics for 
treating pseudomonas aeruginosa caused 
infections. 
35 
 
18 Malik, T., Chauhan, G., 
Rath, G., Kesarkar, 
R.N., Chowdhary, A.S. 
and Goyal, A.K. 
They prepared a thermosensitive nanogel 
in which  Efaverinz (EFV) and gold 
nanoparticles(GNPs) combination 
neosomes were dispersed for completely 
inhibiting Human Immunodeficiency Virus-
1(HIV-1).     
The prepared nanogel formulation of 
combined niosomes was found to be more 
effective inhibitor of HIV-1 by exploiting 
protein-carbohydrate interaction of HIV in 
comparison to other preparations. 
36 
19 El-Feky, G.S., El-Banna, 
S.T., El-Bahy, G.S., 
Abdelrazek, E.M. and 
Kamal, M. 
A silver sulphadiazine nanogel was 
prepared using sodium alginate as polymer 
which could be used topically for healing 
burns by its controlled release anti-
microbial activity.  
The prepared nanogel formulation of silver 
sulfadiazine was found to be more 
therapeutically effective in vivo in 
comparison to other marketed products.  
 
37 
ANASTHETICS 
20 Khongkhunthian, S., 
Sastraruji, T., 
Klayraung, S. and 
Okonogi, S. 
They prepared two modified rice nanogels, 
one loaded with 5% lidocaine 
hydrochloride and other with 20% 
prilocaine hydrochloride for use as local 
anaesthetics in the buccal cavity. 
After evaluation, it was found that prepared 
modified rice nanogels was more effective 
in reducing pain in buccal cavity on needel 
insertion and hence were more clinically 
effective local anaesthetic in comparison to 
other market products. 
38 
21 Hoare, T., Young, S., 
Lawlor, M.W. and 
They prepared a poly(n-
isopropylacrylamide based nanogel  loaded 
The prepared nanogel was found to have a 
prolonged duration of action in comparison 
39 
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Kohane, D.S. with bupivacaine for use as local 
anaesthetics. 
to other local anaesthetics. 
EYES 
22 Moya-Ortega, M.D., 
Alves, T.F., Alvarez-
Lorenzo, C., Concheiro, 
A., Stefánsson, E. 
They prepared a ϒ-cyclodextrin based 
nanogel loaded with Dexamethasone to 
treat ophthalmic inflammation.  
The prepared nanogel was found to be 
more efficient with no side effects in 
comparison to commercially available 
product Maxidex 
40 
23 Ilka, R., Mohseni, M., 
Kianirad, M., 
Naseripour, M., 
Ashtari, K. and 
Mehravi, B. 
They prepared chitosan-alginate 
biopolymers nanogel loaded with Timolol 
Maleate for effective treatment of glaucoma 
through cornea. 
The developed nanogel formulation was 
found to have a higher cornea penetration 
rate and also sustained drug release in 
comparison to other marketed 
formulations. 
41 
FROST BITE 
24 Shen, C.Y., Xu, P.H., 
Shen, B.D., Min, H.Y., 
Li, X.R., Han, J. and 
Yuan, H.L. 
A more therapeutically effective and stable 
nanogel formulation of Ganoderma 
lucidum(GLT) was developed which was 
highly effective for topical application in the 
treatment of frostbite. 
Poorly soluble drug GLT was formulated 
into suitable nanomedicine which was 
found to be more effective for its dermal 
delivery as compared to GLT–carbopol gel 
in the treatment of frostbite.  
42 
NARCOTICS 
25 Asadi, H., 
Rostamizadeh, K., 
Salari, D. and Hamidi, 
M., 2011  
A more therapeutically effective and stable 
nanogel formulation of Ganoderma 
lucidum(GLT) was developed which was 
highly effective for topical application in 
treatment of frostbite. 
Poorly soluble drug GLT was formulated 
into suitable nanomedicine which was 
found to be more effective for its dermal 
delivery as compared to GLT–carbopol gel 
in the treatment of frostbite.  
43 
LUNGS DISEASE 
26 Hoelzer, D., Leiske, 
M.N., Hartlieb, M., Bus, 
T., Pretzel, D., 
Hoeppener, S., Kempe, 
K., Thierbach, R. and 
Schubert  
They prepared a degradable nanogel carrier 
to which imidazoquinoline TLR  7/8 agonist 
is covalently linked which plays an 
important of adjuvant for respiratory 
syncytial virus. 
The study provided strong in-vitro and in-
vivo evidences to choose nanogel carriers of 
imidazoquinoline in comparison to soluble 
polymers of the same for vaccination 
against syncytial virus. 
44 
JOINT DISORDER 
27 Schmitt, F., 
Lagopoulos, L., 
Käuper, P., Rossi, N., 
Busso, N., Barge, J., 
Wagnières, G., Laue, C., 
Wandrey, C. and 
Juillerat-Jeanneret, L. 
They prepared a chitosan nanogel in which 
hyaluronate was surface decorated and 
photosensitizers were encapsulated for 
effectively targeting inflammation inducing 
macrophage in the treatment of rheumatoid 
arthritis. 
The prepared hyaluronate nanogel was 
found to have more therapeutic index and 
increased retention time in comparison to 
free photosensitizers. 
45 
 
Table 2: Other Applications of Nanogels 
S.N. Author name  Description Benefits Ref 
OTHERS 
1 Beloqui, A., Kobitski, 
A.Y., Nienhaus, G.U. 
and Delaittre, G. 
They prepared a single-enzyme 
nanogel in which a hydrophilic and 
polymeric crosslinked nanostructure 
was used for embedding enzyme 
molecule. 
They developed an enzyme nanogel with 
preserved enzyme chemistry  which was 
found to have high catalytic activity similar to 
that of free enzyme in the body. 
46 
2 Drude, N., Winz, O.H., 
Mottaghy, F.M., Roller, 
M., Königs, H., Möller, 
M., Singh, S. and 
Morgenroth, A. 
They reduced glutathione level by 
inhibiting GSH synthesis with the help 
of buthionin sulfoximin for efficient in-
vitro and in-vivo behavior of redox 
sensitive nanogels having disulphide 
linked nanoparticles.  
The data obtained after decreasing GSH level 
showed enhanced circulation half life, 
decreased nanogel distribution and increased 
biodistribution when compared with data 
obtained from nanogel without any change in 
GSH level.  
47 
3 Carr, A.C., Piunova, 
V.A., Maarof, H., Rice, 
J.E. and Swope, W.C.  
 
They studied effect of various organic 
solvents (dichloromethane, diethyl 
ether, toluene, methanol, dimethyl 
sulfoxide, and tetrahydrofuran) on 
drug loading capacity of nanogels star 
polymeric nanoparticle. 
Their work suggested that dichloromethane, 
tetrahydrofuran, and toluene showed  
maximum drug loading capacity in 
comparison to methanol, while diethyl ether 
could not be used as a solvent for drug loading.    
 
48 
4 Bai, X., Xu, S. and 
Wang, L. 
They prepared a nanogel for effective 
recognition of hydrogen sulphide 
which plays a key role in various 
pathological and physiological actions 
in body.The prepared nanogel was  
suffused with gold nanoclusters( 
AuNCs)  using glycol-chitosan (GC) 
polymer matrix.  
The prepared AuNCs@GC nanogel showed 
increased quantum yield to 6-folds, enhanced 
selectivity and sensitivity to aqueous 
hydrogen sulphide and also very good 
biocompatibility and super fluorescence 
stability across the full pH range which leads 
to improved intracellular sulphide imaging. 
49 
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Drug loading and drug release in Nanogels: 
The nanogel systems are very flexible Nanomedicine carriers 
as compared to other systems in respect of drug loading. As 
the drug loading in these systems can be done during or after 
the formulation. Additionally the drug loading is higher and 
spontaneous in case of nanogels. The drug loading process in 
nanogels can involve either covalent conjugation, or physical 
entrapment or self assembly process. Out of these three 
processes, self assembly process is more beneficial as 
compared to the other two processes as it is a cost effective 
and versatile process. It is an independent organization of 
monomers into well defined polymeric structures. 50, 51 
And the drug is released from these nanogels by  
(a) Simple diffusion 
(b) Complete degradation of nanogel 
(c) pH change 
(d) Counter-ions present in the environment 
(e) Other external intermediary energy sources 
Specific polymers are added in composition for imparting 
temperature and photosensitivity in the formulation. Upon 
alteration of temperature, expansion of polymer chain occurs 
which results in release of drug load. Similarly, in case of 
photosensitive polymers cross-linking densities alter which 
affect selling and deswelling of polymers. Finally, change of 
volume control the release of drug from the nanogel. In case 
of pH responsive release, polymers containing weakly acidic 
and basic groups in their structures are chosen. The extent of 
ionization of polymer molecule then governs the swelling 
and deswelling, which controls the drug release from the 
nanogel. For more efficient release control combination of 
these approaches are used. 50, 51 
Drug Targeting Through Nanogels 
Nanogels are gaining importance day by day as they have 
dramatic advantages for targeting any drug in a vast number 
of diseases. They posses both the hydrogel and Nanocarrier’s 
properties. Table No. 1 and 2 provides a list of nanogels, that 
have already been developed for various diseases.  
Nanogels have utilized not only for superficial acute diseases, 
but also entered the critical fatal disease  therapies. These 
delivery systems are now curing the brain disorders, lung 
and liver disorders, cancers, skin diseases, joint disorders, 
ophthalmic, wound healing and vaccine delivery. In parallel 
nanogels have also entered the field of diagnostic imaging. 
(52) Many nanogels have also been patented in various 
countries for various diseases. Table no. 3 summarizes the 
recent patents related to nanogels. 
The brain delivery of various drugs is strictly limited by the 
blood brain barrier and suffers poor bioavailability 
problems. The polymeric nanocarriers with hydrogel system 
have very promising potential to improve the bioavailability 
of such poorly permeable drugs. In the field of brain delivery 
nanogels have been developed for several degenerative 
disorders as well as for brain cancer. For the 
neurodegenerative disorder several oligoneucleotides have 
been formulated as nanogel which successfully crossed the 
BBB. 52 
Skin Diseases- The nanogels can be directly applied to the 
affected area topically. The permeability of drug is enhanced 
by its conversion to the nanoparticle size range. Mohammad 
M. et al prepared nanoparticles of zinc oxide and 
incorporated in the gel and they proved that the antibacterial 
efficiency of drug is improved by this method as compared to 
the existing gels.(30) In another study Panonnummal R. et al 
prepared methotrexate loaded chitin nanogel and found it to 
have high psoriatic activity. 31 
Inflammation and Joint Disorder- Nanogel plays a key role 
in treatment of certain join disorders due to its effective 
targeting towards the inflammation causing macrophages. 
Amongst various joint inflammatory disorders, rheumatoid 
arthritis is the most common disorder. A nanogel has shown 
increased therapeutic index and decreases vascular and 
tissue permeability as compared to conventional system and 
was found to be effective in treatment of certain joint 
disorders. 52, 53 Schmitt et al  prepared hyaluronate nanogel 
having more therapeutic index and less retention time in 
comparison to free photosensitizers.27 
Wound Healing- Nanogel provides many advantages over 
conventional therapy for healing of wounds due to its high 
consonant ability, greater retention time on the applied 
surface (keshavraj and kaffashi 2013) and also enhanced 
healing ability due to its moisturizing nature. 55 
Kobayashi et al. prepared a cholestrol bearing pollulan(CHP) 
nanogel loaded with prostaglandin(PGE1) which when 
tested on induced wound animal model, was found to have 
greater wound size reduction ability in comparison to mere 
cholestrol bearing pollulan(CHP). 56 
Cancer- Many anti-cancer drugs are frequently used for the 
treatement of cancer but they have shows certain 
shortcomings which provide hinderence in the effective 
treatment of cancer.Some of the shortcomings are poor 
permeability, less bioavailability,less retention time and 
faster excretion of drugs .To overcome these shortcomings 
nanogels loaded with anti-cancer drugs were prepared. 57, 58 
Soni et al prepared a N-hexylcarbamoyl-5-flurouracil loaded 
nanogel for treatment of brain tumour and was found to 
have increased retention time and accumulation in brain. 59 
Shi et al prepared a pH sensitive biodegradable nanogel 
loaded with Doxirubicine and the result evident enhanced 
permeability and retention time (EPR) of drug for the 
treatment of hepatic carcinoma.60 Sabita et al prepared a 
chitin nanogel loaded with 5-Flourouracil for the treatment 
of skin carcinoma and the results showed enhanced drug 
loading capacity,enhanced drug release and improved 
retention time. 61 
Eye Disorder- Nanogel are found to be highly effective in 
treatment of eye disorders due to its improved corneal 
bioavailability,less drainage of the formulation from the 
corneal surface and also increased retention time in 
comparison to other carrier system.Moya-Ortega et al.,2012 
prepared a nanogel loaded with dexamethasone in 
combination with gama-cyclodextrine which leads to 
prolonged retention time of drug on the corneal surface. 62 
Diagnosis-  From diagnostic point of view ,nanogel play an 
important role in cell imaging to differentiate cancer cells 
from normal cells to carry out surgeries for removal of 
cancerous cells without effecting normal cells. Hesegawa et 
al. prepared a hybrid nanogel(CHPNH2-QD) by simply mixing 
nanogel quantum-dots (QDs) and amino acid modified 
nanogel of cholesterol bearing  pullulan(CHPNH2), which 
gave long term imaging with greater potential in comparison 
to  a single one( CHPNH2) when tested on certain cancerous 
cell lines. 63 
Immunity:Vaccine- Nanogels can also be employed as 
vaccines and can provide certain advantages like enhanced 
immunity and reduced inflammatory cytokines induced 
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toxicity.Nochi et al prepared a nanogel loaded with non-toxic 
fragment of Clostridium botulinium for treatment of  
mucosal infection disease by intranasal route. 64 
Diabetes- In the treatment of diabetes many glucose 
sensitive nanogels have been prepared with encapsulated 
insulin which releases in response to the level of glucose.Wu 
et al. prepared a silver nanoparticle nanogel of 4-
vinylphenylboronic acid-co-2-(dimethylamino)ethyl acrylate 
) [p(VPBV-DMAEA)] loaded with insulin in which an increase 
in blood glucose level generates optical signals with the help 
of polymer p(VPBV-DMAEA) in nanogel and silver core 
detects optical signals resulting in release of insulin. 65 
 
 
Table 3: Review of Patents on Nanogels 
S. No. Inventors Date Patent Number Description 
1. Se-hoon K.,Chang-
geun L.,Huh,Jung-
Yun,Su J.K.  
  
30/01/2018 KR101823490B1 
South Korea grant 
The invention includes a method of preparation of 
polyamine based polymer nanogel,  a method for 
diagnosis of inflammatory diseases and the ultrasonic 
composition including the contrast medium for 
diagonising the disease. 66 
2.  Young J.K.  
  
10/10/2017 KR101780772B1 
South Korea grant 
The invention describes a process for the ceramide 
preparation for stabilizing the cosmetic composition and 
multilayered nanogel emulsion. 67 
3. Kabanov, A.V. and 
Vinogradov, S.V. 
24/02/2004 US6696089B2 
US grant 
 
This invention is related to  nanogel networks having at 
least one cross-linked polyionic polymer fragment and at 
least one nonionic water-soluble polymer fragment, and 
compositions thereof, having at least one suitable 
biological agent. 68 
4.  Mittal, R., Roy, S.B., 
Kothari, J.S.  
02/05/2017 US9636353B2 
US grant 
 
This invention describe a method for treating, reducing 
or preventing acne. They also described the method for 
reducing incidence, number and severity of acnelesions 
and incidences and severity of adverse events resulting 
from topical application of anti-acne agents resulting in 
improvement of skin tone. It also includes the 
composition and administration of a novel antiacne 
formulation. 69 
5. Jie Y,Lingling 
Z,Dongwei 
Z,Jingxia,Yajuan 
Z,Rui W,Hongze L. 
 
16/10/2018 
 
CN104758945B 
China grant 
 
They invented preparation method and applications for  
thrombolytic drug carrying nanogel for effective delivery 
of protein or peptide drug with synergistic activity. 70 
 
6. Caihua N,Liping 
Z,Gang S.,2017. 
 
  
13/05/2015 
 
 
CN104817660B 
China grant 
 
They developed a method for nano-carboxymethyl 
chitosan nanogel with increased pH and reducing 
sensitivity of drug nanoparticles. 71 
 
7. Wei L. 30/11/2017 
 
CN107811966A 
China grant  
 
The method describes the method of preparation of 
musarin nanogel. The nanoparticles are obtained by 
emulsified solvent evaporation method and then 
dispersed in gel phase  so as to obtain musarin 
nanogel.The prepared nanogel showed high drug loading 
capacity, high stability, possessed core shell structure 
and passes all the crieterias for nanogel preparations. 
The method provided a basis for application of musarin. 
72 
8. Xiaowen S,Jianwei 
Z., Hongbing 
D,Yumin D.  
13/06/2017 CN107141494A 
China grant 
This invention described in detail a preparation method 
of chitin nanogel. The prepared nanogel possessed all 
the ideal characteristics of a nanogel with diameter of 
20nm. The preferred method was easy and simple to 
convert into large scale production. 73 
 
9. Quanchen X,Zhiguo 
W,Xiaoyan 
X,Changquing 
Y,Qiuxia J,Xiulei 
C,Yujin Y.  
  
29/05/2018 
CN104958251A 
China grant 
They invented a method of preparation for hyaluronic 
acid nanogel for the treatment of oral ulcer with 
enhanced clinical treatment efficacy. 74 
10. Fahmy T.M.,Look 
M.,Craft J.  
05/02/2019 US10195144B2 
United States grant 
 
They described the composition and methods for 
preparation of sustained release nanolipogel for treating 
or reducing the symptoms of inflammatory and 
autoimmune disease.The composition embodies 
hydrogel core surrounded with lipid bilayer optionally 
including active molecule as like cyclodextrin or ion-
exchange resin in which one of the agent is 
immunosuppresant. 75 
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11 Thayumanavan 
S.,Ramireddy R.R.  
16/01/2018 US9868821B2 
U S grant 
They invented method of preparation and uses of 
biodegradable polymeric nanogel as nano-carriers and 
can be utilized for diagnostic and drug delivery 
purposes. 76 
12 Mashimo 
K.,Kitamura 
S.,Shojo 
K.,Akiyosha 
I.,Sawada S. 
15/02/2017 JP6082633B2 
Japan grant 
 
They prepared a polysaccharide nanogel with excellent 
wound healing tendency and enhanced safety. 77 
13 Heller  D.A., 
SHAMAY Y. 
  
22/08/2017 US9737614B2 
U S grant 
 
In the present invention,p-selectin targeted polymeric 
drug carrying nanogel for the treatment of cancer and 
other P-selectin targeted disease was developed which 
was having enhanced tumor targeting and reduced 
toxicity. 78 
14 Han-su 
P,Muhammad 
K.,Knoppad U.  
29/04/2016 
 
KR101616400B1 
South Korea grant 
 
The prepared an upgraded anti-fungal nanogel with 
enhanced anti-pathogenic activity specially for the 
treatment of Candida which is an infectious anti-fungal 
disease. 79 
15 Tao W.,Xuemei 
T.,Junyan 
H.,Yuzhang Z.,Min 
X.,Wenzhong C. 
24/08/2016 CN104371066B 
China grant 
 
They invented a preparation method for smart nanogel 
with improved pH and temperature sensitivity. 80 
 
 
CONCLUSION 
From the review about nanogel it can be concluded that the 
nanogels are the versatile carriers exhibiting properties of 
both the nanoparticles and hydrogel. The combination of 
properties of these two systems provides nanogel its 
uniqueness amongst other carriers available. Hydrogel 
system allows them to accommodate any kind and size of a 
therapeutic molecule inside them. And the nanoparticles 
allow deeper penetration, and enhanced retention of the 
drug molecule. With these advancements nanogels can be 
delivered to variety of organ through various routes of 
administration. The review shows that the nanogel is 
covering vast number of diseases ranging from topical 
application for acute irritation and pain to parenteral 
delivery of drug for brain cancer. The studies shown that the 
nanogels even work for the very fatal diseases where other 
treatments cannot work because of their severe side effects. 
The nanogels as nanogels have been proved more effective 
therapies. Nanogels are fluently internalizedin target cells, 
and doesnot show accumulation in non- target tissues 
thereby enhace the bioavailability, reduces therapeutic dose, 
and minimizes harmful side effects. One future goal for 
research in this area should be experiments for reduction of 
toxic effects due to surfactants present as well as more 
clinical trails for launching this flexible and effecient carrier 
system for each and every disease. 
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